According to Ypsomed's latest financial reports the company's current EPS (TTM) is $8.34. In 2024 the company made an earnings per share (EPS) of $8.34 an increase over its 2023 EPS that were of $5.48.
Year | EPS | Change |
---|---|---|
2024 | $8.34 | 52.16% |
2023 | $5.48 | 110.93% |
2022 | $2.60 | 307.14% |
2021 | $0.64 | -49.58% |
2020 | $1.27 | -79.79% |
2019 | $6.26 | 10.54% |
2018 | $5.67 | 18.22% |
2017 | $4.79 | 24.64% |
2016 | $3.85 | 84.88% |
2015 | $2.08 | 30.72% |
2014 | $1.59 | 790.09% |
2013 | $0.18 | -81.6% |
2012 | $0.97 | 58.82% |
2011 | $0.61 | -37.57% |
2010 | $0.98 | -63.35% |
2009 | $2.67 | -14.15% |
2008 | $3.11 | 1106.25% |
2007 | $0.26 | -94.79% |
2006 | $4.96 | 30.04% |
2005 | $3.81 | 195.59% |
2004 | $1.29 | -99.97% |
2003 | $4,567 | 611303.59% |
2002 | $0.75 |